Injectable vs. oral TRT: what the method debate gets wrong

What did @coachdjvanillaface actually say?

The creator argued that injectable testosterone is "always going to be the superior method whether you are male or female," citing three factors: bioavailability, dose adjustability, and serum stability. The core complaint about pellets was that female patients can hit levels "well over 100, 200, maybe even 300 nanograms per deciliter" before declining back down, creating what they called "peaks and valleys full of fluctuations." They also pushed subcutaneous injections with insulin needles as a home-friendly alternative to clinic visits.

To be fair, the creator acknowledged needle aversion is real and didn't dismiss other methods as useless. They framed this as a practical optimization argument, not a medical mandate. That context matters when evaluating whether this is reckless advice or a defensible clinical opinion with some oversimplification baked in.

Does the science back this up?

Partially. The bioavailability argument is the strongest leg of their case. The serum stability claim is real but overstated as a universal truth.

Injectable testosterone cypionate and enanthate do produce predictable pharmacokinetic profiles. Twice-weekly subcutaneous injections specifically have been shown to reduce peak-to-trough variation compared to weekly intramuscular protocols. Davison et al. (2005, Journal of Clinical Endocrinology and Metabolism) documented that transdermal testosterone in women produces lower and more variable serum levels than targeted delivery methods, supporting concerns about gel consistency. Oral testosterone undecanoate has improved but still shows hepatic first-pass effects that reduce predictability.

On pellets: the creator's concern about supratherapeutic levels in women is documented. Glaser et al. (2013, Maturitas) reported mean testosterone levels in pellet-treated women exceeding 200 ng/dL in some cohorts, which sits above the female reference range of roughly 15-70 ng/dL. But "peaks and valleys" is not quite right anatomically. Pellets actually produce relatively flat release curves compared to injections. The problem is the floor, not the swing.

What did they get wrong (or right)?

The biggest factual error is describing pellets as creating "peaks and valleys." That's the opposite of how pellets work. They got the outcome concern right (elevated levels in women) but the mechanism wrong.

Pellets release testosterone at a slow, relatively steady rate driven by surface area dissolution. The profile is actually flatter than injections. The real clinical issue is that once implanted, you cannot titrate down if a patient is overresponding, which is a legitimate and serious safety concern. The FDA has noted this in its assessment of compounded pellet products. So the conclusion (pellets have flexibility problems) is correct. The explanation (peaks and valleys) is not.

What they got right: dose adjustability with injectables is a genuine clinical advantage, particularly for women where therapeutic windows are narrow. The subcutaneous insulin needle recommendation is consistent with published evidence. Olsson et al. (2014, Andrology) confirmed subcutaneous testosterone cypionate is well-absorbed with stable levels at low volumes.

What should you actually know?

No single TRT delivery method is universally superior. The "always" in this video's claim should be a red flag. Patient adherence, skin sensitivity, phlebitis risk, and clinical context all affect which method is actually best for a given individual.

For women specifically, the therapeutic window for testosterone is narrow and evidence for optimal dosing remains limited. The Endocrine Society's 2019 clinical practice guideline explicitly states that testosterone therapy in premenopausal women lacks sufficient safety data for broad recommendation. Pellets in women warrant caution not because of peaks and valleys, but because of the inability to rapidly reverse supratherapeutic exposure, which has been associated with acne, clitoral enlargement, and voice changes in some case reports.

If you are considering any form of testosterone therapy, this video is not a substitute for blood work, a licensed clinician, and a conversation that includes your full medical history. The creator is not your doctor, and neither is a TikTok comment section.